Cargando…

Paraneoplastic Syndromes in Neuro-Ophthalmology

Paraneoplastic neurological syndromes (PNS) occur in about 1 in 300 cases of cancer. The usual mechanism is that an antigen on the cancer sets off an immune response that then cross-reacts with a nervous system antigen. The presentation is usually with a subacute progressive neurological disorder. T...

Descripción completa

Detalles Bibliográficos
Autor principal: Hickman, Simon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795712/
https://www.ncbi.nlm.nih.gov/pubmed/36589030
http://dx.doi.org/10.4103/aian.aian_102_22
_version_ 1784860320761643008
author Hickman, Simon J.
author_facet Hickman, Simon J.
author_sort Hickman, Simon J.
collection PubMed
description Paraneoplastic neurological syndromes (PNS) occur in about 1 in 300 cases of cancer. The usual mechanism is that an antigen on the cancer sets off an immune response that then cross-reacts with a nervous system antigen. The presentation is usually with a subacute progressive neurological disorder. The management of these conditions is usually of both the underlying tumor and immunomodulation to suppress the autoimmune response. There are a number of these conditions that can present to the Neuro-Ophthalmology clinic, either as a discrete condition affecting vision or eye movements or as part of a more widespread neurological disorder. This article will discuss these conditions, their management and prognosis.
format Online
Article
Text
id pubmed-9795712
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-97957122022-12-29 Paraneoplastic Syndromes in Neuro-Ophthalmology Hickman, Simon J. Ann Indian Acad Neurol Neuro-Ophthalmology Supplement Paraneoplastic neurological syndromes (PNS) occur in about 1 in 300 cases of cancer. The usual mechanism is that an antigen on the cancer sets off an immune response that then cross-reacts with a nervous system antigen. The presentation is usually with a subacute progressive neurological disorder. The management of these conditions is usually of both the underlying tumor and immunomodulation to suppress the autoimmune response. There are a number of these conditions that can present to the Neuro-Ophthalmology clinic, either as a discrete condition affecting vision or eye movements or as part of a more widespread neurological disorder. This article will discuss these conditions, their management and prognosis. Wolters Kluwer - Medknow 2022-10 2022-03-25 /pmc/articles/PMC9795712/ /pubmed/36589030 http://dx.doi.org/10.4103/aian.aian_102_22 Text en Copyright: © 2022 Annals of Indian Academy of Neurology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Neuro-Ophthalmology Supplement
Hickman, Simon J.
Paraneoplastic Syndromes in Neuro-Ophthalmology
title Paraneoplastic Syndromes in Neuro-Ophthalmology
title_full Paraneoplastic Syndromes in Neuro-Ophthalmology
title_fullStr Paraneoplastic Syndromes in Neuro-Ophthalmology
title_full_unstemmed Paraneoplastic Syndromes in Neuro-Ophthalmology
title_short Paraneoplastic Syndromes in Neuro-Ophthalmology
title_sort paraneoplastic syndromes in neuro-ophthalmology
topic Neuro-Ophthalmology Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795712/
https://www.ncbi.nlm.nih.gov/pubmed/36589030
http://dx.doi.org/10.4103/aian.aian_102_22
work_keys_str_mv AT hickmansimonj paraneoplasticsyndromesinneuroophthalmology